Finnrick, an independent testing programme, publishes 9 assays for GLP Keep Body Peptide: 6 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 2 did not. Most recent assay 6 Jun 2026.
GLP Keep Body Peptide listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/glp-keep-body-peptide.
GLP Keep Body Peptide is listed as active.
| Product | Assays | Result |
|---|---|---|
| Tirzepatide | 5 | 3 passed, 2 failed |
| Retatrutide | 4 | 3 passed, 0 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Vendor type | Research-use supplier |
These details were read from GLP Keep Body Peptide's own website on 2026-08-10. Pages consulted:
GLP Keep Body Peptide is listed as active and we hold 9 Finnrick assays (6 passing, 2 failing its purity threshold). That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 9 assays for GLP Keep Body Peptide: 6 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 2 did not. Most recent assay 6 Jun 2026.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Go Alpha Labs Peptides Review, Go Tidez Peptides Review, Golden Eagle Peptides Review.